Oramorph SR



Indications and Reactions:

Role Indications Reactions
Primary
Pain 21.7%
Cholecystitis 5.8%
Dyspnoea 5.8%
Hypertension 5.8%
Lung Neoplasm Malignant 5.8%
Musculoskeletal Pain 5.8%
Neuralgia 5.8%
Pain In Extremity 5.8%
Trigeminal Neuralgia 5.8%
Sickle Cell Anaemia 4.3%
Antiplatelet Therapy 2.9%
Breast Cancer Metastatic 2.9%
Constipation 2.9%
Gout 2.9%
Haemoglobin Decreased 2.9%
Increased Viscosity Of Bronchial Secretion 2.9%
Muscle Spasms 2.9%
Myofascial Pain Syndrome 2.9%
Thyroid Disorder 2.9%
Analgesia 1.4%
Completed Suicide 14.8%
Drug Abuse 11.1%
Respiratory Arrest 9.3%
Death 7.4%
Overdose 7.4%
Drug Toxicity 5.6%
Sedation 5.6%
Sickle Cell Anaemia 5.6%
Accidental Overdose 3.7%
Memory Impairment 3.7%
Somnolence 3.7%
Swollen Tongue 3.7%
Transient Ischaemic Attack 3.7%
Unresponsive To Stimuli 3.7%
Cardiac Arrest 1.9%
Circumstance Or Information Capable Of Leading To Medication Error 1.9%
Deafness 1.9%
Drug Ineffective 1.9%
Drug Prescribing Error 1.9%
Haemodynamic Instability 1.9%
Secondary
Product Used For Unknown Indication 31.0%
Drug Use For Unknown Indication 15.3%
Pain 14.0%
Abdominal Pain 9.2%
Depression 5.9%
Analgesia 2.5%
Parkinson's Disease 2.4%
Laxative Supportive Care 2.1%
Constipation 1.8%
Analgesic Therapy 1.7%
Non-small Cell Lung Cancer 1.7%
Prophylaxis Of Nausea And Vomiting 1.7%
Tumour Pain 1.7%
Breast Cancer 1.6%
Insomnia 1.4%
Multiple Myeloma 1.4%
Malaise 1.3%
Prophylaxis 1.3%
Rheumatoid Arthritis 1.1%
Cholecystitis 0.8%
Abdominal Pain 26.4%
Cardio-respiratory Arrest 15.5%
Multiple Drug Overdose 7.8%
Pain 6.2%
Miosis 5.4%
Death 3.9%
Renal Failure Acute 3.9%
Vomiting 3.9%
Drug Toxicity 3.1%
Pollakiuria 3.1%
White Blood Cell Count Increased 3.1%
Lethargy 2.3%
Overdose 2.3%
Respiratory Arrest 2.3%
Respiratory Depression 2.3%
Swollen Tongue 2.3%
Confusional State 1.6%
Constipation 1.6%
Depression 1.6%
Drug Withdrawal Syndrome 1.6%
Concomitant
Product Used For Unknown Indication 21.1%
Drug Use For Unknown Indication 17.3%
Pain 16.8%
Crohn's Disease 4.9%
Constipation 4.7%
Nausea 4.2%
Non-small Cell Lung Cancer 3.9%
Prophylaxis 3.7%
Multiple Myeloma 3.5%
Analgesic Therapy 3.3%
Hypertension 2.4%
Acute Myeloid Leukaemia 2.4%
Rheumatoid Arthritis 1.9%
Breast Cancer 1.5%
Diabetes Mellitus 1.5%
Depression 1.5%
Insomnia 1.4%
Antifungal Prophylaxis 1.4%
Rhabdomyosarcoma 1.4%
Anxiety 1.3%
Vomiting 16.0%
Renal Failure Acute 6.8%
Death 5.8%
Pain 5.8%
Thrombocytopenia 5.5%
Weight Decreased 5.5%
Inhibitory Drug Interaction 5.1%
Nausea 5.1%
Pyrexia 4.4%
Vision Blurred 4.4%
Upper Gastrointestinal Haemorrhage 4.1%
Weight Increased 4.1%
Hypercalcaemia 3.8%
Neutropenia 3.8%
Somnolence 3.8%
Pneumonia 3.4%
Sepsis 3.4%
Drug Interaction 3.1%
Pancytopenia 3.1%
Premature Baby 3.1%
Interacting
Pain 84.4%
Postoperative Care 9.4%
Product Used For Unknown Indication 6.3%
White Blood Cell Count Increased 44.4%
Stevens-johnson Syndrome 33.3%
Respiratory Arrest 22.2%